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Abstract
Background In our institution, we have redefined our criteria
for direct availability of red blood cell (RBC) units in the
operation room. In this study, we sought to evaluate the safety
of applying this new logistical policy of blood transfusion in
the first preliminary group of patients.
Methods In March 2010, we started a new policy concerning
the elective availability of RBC units in the operation room.
This policy was called: No Elective Red Cells (NERC) pro-
gram. The program was applied for patients undergoing pri-
mary isolated coronary artery bypass grafting (CABG) or
single valve surgery. No elective RBC units were preopera-
tively ordered for these patients. In case of urgent need, blood
was delivered to the operating room within 20 min. The
present study includes the first 500 patients who were man-
aged according to this policy. Logistic regression analyses
were performed to investigate the impact of biomedical vari-
ables on fulfilling this NERC program.
Results The majority of patients (n=409, 81 %) did not re-
ceive any RBCs during the hospital stay. In patients who did
receive RBCs (n=91, 19 %), 11 patients (2.2 %) received
RBCs after 24 h postoperatively. Female gender, left ventric-
ular ejection fraction (LVEF) and EuroSCORE were signifi-
cant predictors for the need of blood transfusion (OR=3.12;
2.79; 1.17 respectively).
Conclusion In a selected group of patients, it is safe to per-
form cardiac surgery without the immediate availability of
RBCs in the operating room. Transfusion was avoided in
81 % of these patients. Female gender, LVEF and
EuroSCORE were associated with blood transfusion.
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Introduction
Perioperative transfusion of red blood cells (RBCs) has been
associated with increased mortality, morbidity, costs and de-
creased long-term survival after cardiac surgery [1, 2]. The
severity of the adverse effects of perioperative RBC transfu-
sion is dose-dependent. Unnecessary transfusion might cause
postoperative complications and subsequent hospitalisation
costs [1, 3]. In an earlier report [4], we identified the indepen-
dent, patient-related risk factors of RBC transfusion after
coronary artery bypass grafting (CABG). Identification of
these risk factors led us to follow a new policy concerning
the direct availability of packed RBCs in the operating theatre.
It was standard practice in our hospital to have two units of
RBCs directly available in the operating theatre for every
patient who is scheduled for an elective CABG. If these two
units are not used, they are returned to the laboratory to be
used for another patient. The quality of these RBCs is
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sometimes reduced and the RBCs cannot be used anymore.
Since March 2010, we have followed a policy that is called:
No Elective Red Cells (NERC) protocol. With this new pro-
tocol, in a selected group of patients, no units of RBCs are
directly available in the operating theatre. According to this
protocol, RBCs that are available in the blood bank are deliv-
ered into the operating room within 20 min after request.
In the present study, we have analysed our results of the




In our institution, we have started a new strategy concerning
direct availability of RBC units in the operating room for a
selected group of patients undergoing cardiac surgery. In this
group of patients, only ABO typing and screening for irregular
antibodies without cross matching were performed. Units of
RBCs were kept in the hospital’s blood bank. All patients
were examined in the preoperative screening in the outpatient
clinic to select suitable candidates for the NERC program. For
patients included in the protocol, no RBCs were ordered
before the operation. Patients included in the NERC program
were screened for blood type and irregular antibodies the day
before surgery. In case of urgent need for transfusion of RBCs
during or immediately after the operation, the local blood
bank prepared the RBCs, including electronic cross matching,
and delivered them within 20 min. Uncross-matched blood
was not given to any of the patients in this population.
We always perform a double ABO screening including the
Rh typing. In addition, we performed one screening on irreg-
ular antibodies for every patient. These tests are valid for 48 h.
Afterwards, a double ABO and antibody screenings should be
repeated.
Patients
The study included the first consecutive 500 patients who
were managed according to the NERC protocol starting in
March 2010. Approval was obtained from the institution’s
research review board that waived the need for informed
consent. Data of demographics, operative techniques, blood
transfusions and adverse events were prospectively collected
in the computerised database of our department.
Patients were managed according to the NERC protocol
when they fulfilled the following criteria:
– Isolated primary coronary artery bypass grafting
(CABG), isolated aortic valve replacement (AVR) or
isolated mitral valve surgery.
– Preoperative haemoglobin (Hb) level of >7.0 mmol/L
(11.3 g/dL).
– Body surface area (BSA) of >1.7 m2.
– Negative test for irregular antibodies.
Patients were excluded from the NERC protocol in case of
the following criteria:
– Combined CABG and/or valve surgery.
– Prior cardiac surgery.
– Positive test for irregular antibodies.
Operative technique
All patients received short-acting anaesthetic drugs to facili-
tate early extubation and rapid recovery according to our daily
practice. Normothermic extracorporeal circulation (ECC) was
performed using non-pulsatile flow. Cold crystalloid
cardioplegia (St Thomas’ solution) or warm blood
cardioplegia was used to induce and maintain cardioplegic
cardiac arrest, according to the surgeon’s preference. Cell
saver was used to collect all shed and/or residual blood, which
was retransfused immediately after the operation.
Indications of RBC transfusion
In our hospital, transfusion of one or more units of RBC is
indicated in the postoperative period in case of a haemoglobin
level of <5 mmol/L (8 g/dL) or a haematocrit value of <0.25. A
haemoglobin level of <6 mmol/L (9.5 g/dL) is adopted in case
of haemodynamically unstable patients or patients with post-
operative ischaemia or excessive bleeding. If the patient did not
fulfil any of these criteria, no blood transfusion was given.
Statistics
Continuous variables are expressed as mean±SD and categor-
ical data are expressed as numbers (percentage). Univariate
logistic regression analyses were performed to investigate the
impact of biomedical variables on fulfilling the NERC proto-
col. A P-value<0.05 was used for all tests to indicate statistical
significance. Odds ratios (OR) with a confidence interval (CI)
of 95 %with p-values are reported. All statistical analyses were
performed using SPPS version 17.0 (SPSS Inc, Chicago, IL).
Results
Starting in March 2010, 500 consecutive patients underwent
cardiac surgery in our hospital and fulfilled the criteria for the
NERC protocol. Demographic data and comorbidities are
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shown in Table 1. The majority of patients were male (82 %).
The following comorbidities were present: diabetes (19 %),
hypertension (52.8 %), severe renal function impairment
(1.2 %), chronic obstructive pulmonary disease (COPD)
(9 %), peripheral vascular disease (PVD) (13.6 %), history
of preoperative atrial fibrillation (4.4 %) and preoperative
myocardial infarction (37.6 %). The mean logistic
EuroSCORE was 3.2 ± 3.3 and the mean additive
EuroSCORE was 3.1±2.3.
Table 2 shows the type of the operations performed. The
majority of patients underwent coronary artery bypass grafting
(CABG) including on pump (74 %) and off pump (OPCAB)
(12 %) surgery. An overview of the number of transfusions of
blood products in the first 24 h is given in Table 3.
The number of patients who did not receive any RBCs
during hospital stay was 409 (81 %). Sixty-one patients
(12.2 %) received 1–2 units of blood and 14 patients (2.8 %)
received 3–5 units of blood within the first 24 h after surgery.
In all these patients, blood was available within 20 min as
planned. Only 11 patients (2.2 %) received RBCs on the ward
after 24 h of surgery.
The mean serum haemoglobin was 6.4±0.8 mmol/l (10.3±
1.3 g/dL) on the first postoperative day, and 6.8±0.8 mmol/l
(11±1.3 g/dL) on the third postoperative day.
Table 3 shows the number of transfused blood products, the
level of serum haemoglobin, transfusion of RBCs as well as
fresh frozen plasma (FFP) units. The serum haemoglobin
levels in the first and third postoperative days are also shown.
Postoperative complications (Table 4) included re-
exploration for bleeding (4.6 %), myocardial infarction
(3.2 %), cerebrovascular accident (CVA) (0.4 %) and deep
sternal wound infection (0.6 %). Results of the univariate
logistic regression analysis for the need for blood transfusion
are shown in Table 5. Female gender (OR=3.12) and LVEF
<35 % (OR=2.79) predicted a higher risk of blood transfu-
sion. A higher logistic (OR=1.06) and a higher additive
EuroSCORE (OR=1.17) are significant predictors for the
need of RBC transfusion.
Discussion
This study demonstrated, in a selected group of patients, that it is
safe to perform cardiac surgery without the immediate availabil-
ity of RBCs in the operating room. This resulted in a consider-
able reduction in cross-matching and transportation with possi-
ble damage of non-used RBC. We used data from an earlier
report of our group [4] to identify patients with a relatively low
risk for receiving perioperative RBC transfusions.
Transfusion of RBCs is not only associated with an in-
crease in morbidity and mortality, but also with a longer ICU
stay and total hospital stay [1]. Moreover, the effect of dura-
tion of storage of RBC on morbidity has been addressed
[5–10]. In an earlier retrospective analysis of 10,626 patients
undergoing cardiac surgery in our institution [2], we found a
significant correlation between the number of RBC units
received by the patients and the incidence of early mortality.
McKenny et al. [9] also found the number of transfused RBC
units to be associated with adverse outcome and longer hos-
pital stay after cardiac surgery. Koch et al. [11] found signif-
icantly reduced survival among transfused patients compared
with non-transfused patients. Both early (6 months) and late
hazard phases (up to 10 years) showed that transfusion of red
cells is associated with a decreased survival in isolated CABG
patients. According to these authors, attention should be di-
rected toward blood conservation methods and a more judi-
cious use of the RBCs [11].
One of the primary rationales of the NERC protocol is to
help maintenance of adequate preservation of the RBCs. Non-
used units of blood must be returned back to the blood bank
Table 1 Demographic data and comorbidities
Variable Incidence
Male gender 411 (82.2 %)
Age 63.8±9.7 (29–87)
Diabetes 93 (19 %)
Hypertension 264 (52.8 %)
Serum haemoglobin (mmol/L) 8.7±0.7 (7.0–10.7)
Serum creatinine (mmol/L) 94.6±27.8 (54–390)
Serum creatinine >200 mmol/L 6 (1.2 %)
COPD 45 (9 %)
PVD 68 (13.6 %)
Atrial fibrillation 22 (4.4 %)
Previous MI 182 (37.6 %)
LVEF <35 % 19 (3.8 %)
Logistic EuroSCORE 3.2±3.3 (1–35)
Additive EuroSCORE 3.1±2.3 (0–11)
Data are presented as numbers (%) or mean±SD
COPD chronic obstructive pulmonary disease, LVEF left ventricular
ejection fraction, MI myocardial infarction, PVD peripheral vascular
disease
Table 2 Type of surgical procedure
Operation Number (%) Mean duration of ECC
CABG 373 (74.5 %) 67±26
OPCAB 60 (12 %) N/A
AVR 50 (10 %) 77±20
MVR/MV repair 17 (3.4 %) 85±35
Data are numbers (%) or mean±SD
AVR aortic valve replacement, CABG coronary artery bypass grafting,
ECC extracorporeal circulation, MV mitral valve, MVR mitral valve
replacement, OPCAB off pump coronary artery bypass grafting
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for further use. However, the quality of these RBC units is
likely to be adversely influenced by the improper reservation
in the operation room as well as during transport [12]. The
value of transfusion of these RBC units is physiologically less
effective and can even increase the incidence of postoperative
complications [13–15].
The effect of storage time of RBCs on the outcome after
cardiac surgery has gained an increasing interest in recent
literature. In an earlier study, storage time of the RBCs was
not found to be a significant predictor of early or late mortality
after CABG in our centre [5]. The endpoint of that study was
all-cause mortality without analysing the effect of storage time
of RBCs on morbidity.
On the other hand, Sanders et al. [10] found that patients
receiving older blood have an increased incidence of
prolonged hospital stay and renal complications compared
with those receiving new blood [10]. Koch et al.[6] also found
a correlation between transfusion of old blood and mortality
and both renal and pulmonary complications after cardiac
surgery. The controversy between different reports might be
explained by the various patient populations studied, differ-
ences in study design or analysis, or different methods of
blood storage. [5]
The criteria of selected patients who are candidates of this
NERC protocol are of utmost importance. We applied these
criteria after studying the risk factors of perioperative
transfusion in our centre [4]. These criteria can vary in differ-
ent centres and according to the availability of RBC units. If
the blood is not electively ordered, it must be possible to
deliver it on time if urgently needed.
Several blood conservation strategies [16–18] have
been proposed in order to improve outcome after cardiac
surgery, reduce the need for donor blood and hence
lower the overall costs of transfusion. A wide variation
in clinical practice and the application of guidelines have
been reported in as many as 1402 surveys in 1061
institutions in the United States and Canada [19] Most
of these studies examined liberal versus restrictive trans-
fusion practices in cardiac surgery. However, there is no
prospective randomised trial comparing the outcomes of
a program that practises blood conservation versus the
common practice of blood use in cardiac surgery [20].
Our NERC protocol is prospectively designed and the
data of patients are prospectively collected as well. Only
19 % of the patients needed blood transfusions during
the whole hospital stay. In all these patients, the blood
needed was immediately available on site in the hospital.
In the present study, the incidence of postoperative com-
plications is comparable with the general incidence of
complications in our institution as demonstrated in pre-
vious studies of similar patients in our department [2].
Univariate predictors of postoperative need for blood
transfusion were found to be gender (female sex), LVEF
<35 %, logistic and additive EuroSCORE.
The use of cell saver for shed blood or residual blood is a
routine in our daily cardiac surgical practice. Current evidence
suggests that the use of a cell saver reduces exposure to
allergenic blood products or red blood cell transfusion for
patients undergoing cardiac surgery [21].
Table 3 Transfusions of blood products and postoperative serum
haemoglobin
RBC transfusions within 24 h
1–2 units 61 (12.2 %)
3–5 units 14 (2.8 %)
> 5 units 5 (1 %)
Patients with RBC transfusion after 24 h 11 (2.2 %)
Patients with no RBC transfusion during hospital stay 409 (81 %)
Patients with transfusion of fresh frozen plasma 46 (9.2 %)
Patients with transfusion of platelets 23 (4.6 %)
Serum haemoglobin on the 1st postoperative day (mmol/L) 6.4±0.8
Serum haemoglobin on the 3rd postoperative day (mmol/L) 6.8±0.8
Data are presented as numbers (%) or mean±SD
Table 4 Postoperative complications
Complication Incidence
Re-exploration for bleeding 24 (4.6 %)
Myocardial infarction 16 (3.2 %)
CVA 2 (0.4 %)
Deep sternal wound infection 3 (0.6 %)
Operative mortality 1 (0.2 %)
CVA cerebrovascular accident
Table 5 Univariate logistic regression analysis for predictors of periop-
erative red blood cell transfusion
Variable OR (95 % CI) p-value
Age* 1.02 (0.99–1.04) 0.060
Female sex 3.12 (1.86–5.23) <0.0001
Diabetes 0.89 (0.49–1.61) 0.703
Hypertension 1.44 (0.91–2.30) 0.117
COPD 1.51 (0.73–3.12) 0.258
PVD 0.74 (0.36–1.52) 0.423
LVEF <35 % 2.79 (1.06–7.31) 0.036
Preoperative serum creatinine* 1.00 (0.99–1.00) 0.923
Logistic EuroSCORE* 1.06 (1.00–1.12) 0.043
Additive EuroSCORE* 1.17 (1.06–1.29) 0.001
OR odds ratio, CI confidence interval, COPD chronic obstructive pulmo-
nary disease, PVD peripheral vascular disease, LVEF left ventricular
ejection fraction
* used as a continuous variable
Neth Heart J (2015) 23:28–32 31
Limitations
The results of this observational single-centre study must be
interpreted with caution. Our findings were the result of the
local protocol agreed upon by a team of anaesthesiologists,
ICU physicians, cardiac surgeons and the blood bank. Wheth-
er the same results can be applied to other institutions remains
to be investigated. The lack of a control group is also a
shortcoming. However, matching this group with another
group that was operated earlier was not convenient.
Conclusions
In a selected group of patients, it is safe to perform cardiac
surgery without the immediate availability of RBCs in the
operating room. Preoperative univariate predictors of the need
for postoperative RBC transfusion were female gender, left
ventricular function (LVEF) <35 % and the EuroSCORE.
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